0.1750
-0.0050
(-2.78%)
At close: January 10 at 3:59:50 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
5,147.5790
6,120.7610
8,658.2420
Total Liabilities Net Minority Interest
1,487.7430
107.0480
113.9790
Total Equity Gross Minority Interest
3,659.8360
6,013.7130
8,544.2630
Total Capitalization
4,992.9320
6,013.7130
8,544.2630
Common Stock Equity
3,659.8360
6,013.7130
8,544.2630
Net Tangible Assets
-855.2150
962.5530
2,956.9940
Working Capital
477.8810
962.5530
2,956.9940
Invested Capital
4,992.9320
6,013.7130
8,544.2630
Tangible Book Value
-855.2150
962.5530
2,956.9940
Total Debt
1,333.0960
--
--
Net Debt
896.7830
--
--
Share Issued
70,084.9250
69,829.5000
69,808.0000
Ordinary Shares Number
70,084.9250
69,829.5000
69,808.0000
12/31/2021 - 4/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNFA TNF Pharmaceuticals, Inc.
1.2650
+1.20%
HEM.V Hemostemix Inc.
0.2400
+20.00%
NGEN.V NervGen Pharma Corp.
3.0900
+3.69%
ENBI.CN Entheon Biomedical Corp.
0.2750
+7.84%
BLAB.CN Britannia Life Sciences Inc.
0.0850
0.00%
IUGNF Imugene Limited
0.0290
-3.65%
SVA.TO Sernova Corp.
0.2250
0.00%
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
MNPR Monopar Therapeutics Inc.
25.35
+3.64%